Press Release

dPCR and qPCR Products Market to Grow with a CAGR of 7.20% through 2029

Continuous advancements in PCR technologies and growing importance of PCR in biomarker discovery is expected to drive the Global dPCR and qPCR Products Market growth in the forecast period, 2025-2029.

According to TechSci Research report, “dPCR and qPCR Products Market – Global Industry Size, Share, Trends, Competition Forecast & Opportunities, 2029F”, the Global dPCR and qPCR Products Market stood at USD 8.12 billion in 2023 and is anticipated to grow with a CAGR of 7.20% through 2029. The dPCR and qPCR industry is projected to witness substantial growth in the near future. This is attributed to the growing demand for precise, accurate, and efficient detection of nucleic acids across various applications, including gene expression analysis, disease diagnosis, and food safety testing.

The growth of the market is anticipated to be primarily fueled by advancements in highly sensitive and specific instruments, reagents, and assays for digital PCR (dPCR) and quantitative PCR (qPCR). Furthermore, the introduction of next-generation sequencing (NGS) methods, including single-cell sequencing, is poised to drive further expansion in the dPCR and qPCR industry. The increasing demand for personalized medicine and rapid diagnostics is expected to unlock numerous opportunities within the dPCR and qPCR sector.

Factors such as the rising incidence and prevalence of target infectious diseases and genetic disorders, continuous technological advancements in PCR technologies, growing significance of PCR in biomarker discovery, and increasing investments and funding are contributing to the growth of the market. The escalating prevalence of genetic disorders and major infectious diseases, coupled with the growing utilization of biomarker profiling for disease diagnostics, are significant drivers fueling the demand for technologically advanced PCR tests in the foreseeable future.

In the coming years, significant technological advancements, augmented investments, funding, and grants are expected to further drive the demand for digital PCR across various applications. The transition from plant-based to genome-based drug discovery is also expected to present opportunities for market growth. However, technical limitations associated with PCR and the increased cost of PCR devices may hinder market growth. Nevertheless, the development of portable, compact, and lab-on-chip PCR devices, along with technological integration, is expected to drive market expansion. Increased investments and access to funding and grants are supporting the surge in research and development activities, with governments and federal organizations worldwide increasingly recognizing the significance of qPCR and dPCR technologies in genomics research. Numerous financing initiatives have been undertaken to support genomic research in the qPCR and dPCR industries over the past decade.


Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Global dPCR and qPCR Products Market

The Global dPCR and qPCR Products Market is segmented into product, application, end user, regional distribution, and company.

Based on By Priduct, The dPCR and qPCR Products Market is segmented into reagents & consumables, instruments, and software. It is anticipated that the reagents and consumables segment will dominate, holding the largest market share. This is attributed to the increasing adoption of dPCR and qPCR products by researchers and healthcare professionals. The trend is driven by the automation and miniaturization of qPCR/dPCR instruments, the availability of advanced software, and customized laboratory reagents. Moreover, the global uptake of MIQE guidelines is bolstering the use of qPCR/dPCR reagents among researchers. Additionally, the expanding applications of qPCR, offering technological advantages over traditional PCR, such as real-time analysis and reduced analysis time, are expected to further drive the growth of the reagents and consumables market.

Based on region, The North America segment is poised for growth throughout the forecast period. According to regional analysis, North America emerged as the leader in the dPCR and qPCR Products Market in 2023, with Europe following closely behind. The expansion of the North American dPCR and qPCR Products Market is driven by several factors, including the increasing adoption of innovative genomic analysis products, the availability of substantial research and development funding, a robust research infrastructure, the growing utilization of PCR techniques in clinical diagnostics and forensics, and the early commercialization of qPCR/dPCR products in the region. North America is anticipated to maintain its dominance in the overall market throughout the forecast period, propelled by various factors such as the presence of key industry players, a high prevalence of chronic diseases, and a well-established healthcare infrastructure. Moreover, beneficial government initiatives and a rise in research partnerships are expected to further stimulate market growth. Among the countries in this region, the United States holds the largest share due to its supportive healthcare policies, a substantial patient population, and a mature healthcare market.


Major companies operating in Global dPCR and qPCR Products Market are:

  • Abbott Laboratories, Inc.
  • Agilent Technologies, Inc.
  • Analytik Jena AG
  • Becton Dickinson and Company
  • Bio Molecular Systems Pty Ltd
  • Biomeme Inc.
  • Biomérieux S.A.
  • Bioneer Corporation
  • Bio-Rad Laboratories, Inc.
  • Cole-Parmer Instrument Company llc


Download Free Sample Report

Customers can also request for 10% free customization on this report


“Factors such as the growth in the geriatric population, rising incidence of infectious diseases and genetic disorders, technological advancements in the field of PCR, and increasing investments and availability of funds for PCR-based research are driving the growth of the global dPCR and qPCR Products Market. Moreover, the market is being propelled by the increasing advancements in PCR techniques and research activities that utilize PCR. The expansion of healthcare infrastructure, an increase in healthcare expenditure, and lower procedural costs for qPCR and dPCR-based illness diagnostics are significant drivers for these markets. The growing healthcare infrastructure in emerging countries is accompanied by the rapid upgrading of healthcare facilities, which leads to higher demand for clinical diagnostic procedures in diagnostic laboratories. This, in turn, results in increased sales of clinical qPCR and dPCR products. Additionally, increased public-private investments to raise awareness about illness diagnostics and the introduction of technologically sophisticated products are contributing to the forward momentum of the Global dPCR and qPCR Products Market”, said Mr. Karan Chechi, Research Director of TechSci Research, a research-based management consulting firm.

dPCR and qPCR Products Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Reagents & Consumables, Instruments, And Software), By Application (Clinical Applications, And Forensic Applications), By End User (Hospitals & Diagnostic Centres, Research Laboratories & Academic Institutes, Clinical Research Organizations, And Others), By Region and Competition, 2019-2029F", has evaluated the future growth potential of Global dPCR and qPCR Products Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global dPCR and qPCR Products Market.



TechSci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +1-332-258-6602

Email: [email protected]


Relevant News